Literature DB >> 3546414

Etretinate therapy.

C N Ellis, J J Voorhees.   

Abstract

Etretinate is a retinoid given orally for the treatment of psoriasis and many other dermatoses. Side effects are similar to the hypervitaminosis A condition. Etretinate represents a substantial advance in dermatologic therapy.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3546414

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  14 in total

1.  Fatal toxic epidermal necrolysis associated with etretinate.

Authors:  A McIvor
Journal:  BMJ       Date:  1992-02-29

Review 2.  50 Years of Topical Retinoids for Acne: Evolution of Treatment.

Authors:  Hilary Baldwin; Guy Webster; Linda Stein Gold; Valerie Callender; Fran E Cook-Bolden; Eric Guenin
Journal:  Am J Clin Dermatol       Date:  2021-05       Impact factor: 7.403

3.  Dose-proportional absorption of etretinate after doses of 25, 50, 75, and 100 mg.

Authors:  R J Wills; L C Rodriguez; A H Lin; C Puccini; W A Colburn
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

Review 4.  Comparative tolerability of systemic treatments for plaque-type psoriasis.

Authors:  Stacy L McClure; Jayme Valentine; Kenneth B Gordon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Current treatment of psoriasis.

Authors:  J D Epstein
Journal:  Can Fam Physician       Date:  1987-10       Impact factor: 3.275

Review 6.  Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.

Authors:  D D Tang-Liu; R M Matsumoto; J I Usansky
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

Review 7.  Adverse effects of retinoids.

Authors:  M David; E Hodak; N J Lowe
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

Review 8.  Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases.

Authors:  F G Larsen; F Nielsen-Kudsk; P Jakobsen; K Weismann; K Kragballe
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

9.  Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid. A clinical and immunohistochemical study.

Authors:  P M Steijlen; D O Reifenschweiler; F C Ramaekers; G N van Muijen; R Happle; M Link; D J Ruiter; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

10.  The use of gemfibrozil in a patient with chronic myelogenous leukemia to successfully manage retinoid-induced hypertriglyceridemia.

Authors:  P R Cohen
Journal:  Clin Investig       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.